Shielding

Shielding is a measure to protect people who are clinically extremely vulnerable by minimising all interaction between those who are extremely vulnerable and others.

The Government is strongly advising people with serious underlying health conditions (listed below), which put them at very high risk of severe illness from coronavirus (COVID-19), to rigorously follow shielding measures in order to keep themselves safe.

Underlying health conditions:

  • Solid organ transplant recipients.
  • People with specific cancers:
    -people with cancer who are undergoing active chemotherapy or radical radiotherapy for lung cancer
    -people with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment
    -people having immunotherapy or other continuing antibody treatments for cancer
    -people having other targeted cancer treatments which can affect the immune system, such as protein kinase inhibitors or PARP inhibitors
    -people who have had bone marrow or stem cell transplants in the last 6 months, or who are still taking immunosuppression drugs
  • People with severe respiratory conditions including all cystic fibrosis, severe asthma and severe COPD.
  • People with rare diseases and inborn errors of metabolism that significantly increase the risk of infections (such as SCID, homozygous sickle cell).
  • People on immunosuppression therapies sufficient to significantly increase risk of infection.
  • Women who are pregnant with significant heart disease, congenital or acquired.
     

Planning meetings have been taking place to map out the council and health and social care support for the national ‘shielding’ plans to support extremely vulnerable residents.

A phone-line has been installed to provide a local contact support to people in Inverclyde receiving national communication about this from the NHS.